Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Study of Potential Therapeutic Effect of Oral Zinc in Manifesting Carriers of Wilson Disease

NCT03659331 is registered in ClinicalTrials.gov with Prof. Elon Pras as lead sponsor.

NCT NCT03659331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03659331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Study of Potential Therapeutic Effect of Oral Zinc in Manifesting Carriers of Wilson Disease
Lead sponsor
Prof. Elon Pras
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2018
Completion date
October 31, 2019
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

wilson disease